tiprankstipranks
Trending News
More News >
Genetec Corp. (JP:4492)
:4492
Japanese Market
Advertisement

Genetec Corp. (4492) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4492

Genetec Corp.

(4492)

Rating:73Outperform
Price Target:
¥496.00
▲(7.13%Upside)
Genetec Corp.'s overall stock score is bolstered by strong financial performance and attractive valuation. While technical analysis indicates mixed short-term signals, the company's solid financial foundation and favorable valuation metrics position it well for potential growth and stability in the long run.

Genetec Corp. (4492) vs. iShares MSCI Japan ETF (EWJ)

Genetec Corp. Business Overview & Revenue Model

Company DescriptionGenetec Corp. (4492) is a technology company specializing in the development and manufacturing of advanced electronic and optical components. The company operates within sectors including semiconductor manufacturing, precision equipment, and optical technology. Genetec's core products and services include the production of semiconductor devices, precision measuring instruments, and other related technologies aimed at enhancing efficiency and performance across various industrial applications.
How the Company Makes MoneyGenetec Corp. generates revenue primarily through the sale of its semiconductor and optical technology products. The company manufactures and distributes high-performance components that are critical in the production and operation of electronic devices and equipment. Key revenue streams include sales to industrial clients in the technology and electronics sectors, where the demand for precision and efficiency drives the need for Genetec's products. Significant partnerships with leading technology firms and manufacturers amplify its market reach and contribute to its earnings. The company's expertise in innovation and technological advancements positions it as a leader in its field, further stabilizing and growing its revenue base.

Genetec Corp. Financial Statement Overview

Summary
Genetec Corp. is performing well across its financial statements, with strong revenue growth, profitability, and a solid balance sheet with low leverage. While cash flow management shows room for improvement, the overall financial health is robust, indicating positive growth prospects.
Income Statement
78
Positive
Genetec Corp. demonstrates healthy revenue growth, with a notable increase from 2024 to 2025. The gross profit margin is strong at approximately 40%, indicating good cost control relative to revenue. Net profit margin is also healthy at around 5%, showing profitability. However, the EBIT margin is moderate, suggesting room for operational efficiency improvements.
Balance Sheet
82
Very Positive
The company has a relatively low debt-to-equity ratio, indicating low financial leverage, which is favorable. The return on equity (ROE) is robust, reflecting efficient use of shareholder capital. The equity ratio is stable, suggesting a strong capital base and financial stability.
Cash Flow
72
Positive
Genetec Corp. has shown fluctuations in free cash flow but maintains a positive trajectory. The operating cash flow to net income ratio is positive, indicating efficient cash generation from operations. However, there is room for improvement in free cash flow management.
BreakdownMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue8.12B7.15B5.86B4.68B4.08B
Gross Profit3.27B2.91B2.32B1.96B1.56B
EBITDA829.40M783.24M245.09M153.83M301.93M
Net Income421.12M414.77M23.76M56.64M173.41M
Balance Sheet
Total Assets7.15B4.52B4.12B3.25B2.84B
Cash, Cash Equivalents and Short-Term Investments1.99B1.17B1.08B1.04B1.48B
Total Debt2.26B640.00M976.09M50.62M75.00M
Total Liabilities4.75B2.31B2.26B1.39B1.02B
Stockholders Equity2.40B2.21B1.87B1.86B1.83B
Cash Flow
Free Cash Flow384.76M495.19M-359.44M-176.37M406.28M
Operating Cash Flow451.42M602.37M-223.12M-24.03M443.26M
Investing Cash Flow-388.73M-55.73M-439.20M-98.15M-38.53M
Financing Cash Flow655.92M-410.02M714.93M-94.71M-76.04M

Genetec Corp. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price463.00
Price Trends
50DMA
445.74
Positive
100DMA
476.78
Negative
200DMA
520.36
Negative
Market Momentum
MACD
2.81
Negative
RSI
62.71
Neutral
STOCH
63.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4492, the sentiment is Positive. The current price of 463 is above the 20-day moving average (MA) of 449.85, above the 50-day MA of 445.74, and below the 200-day MA of 520.36, indicating a neutral trend. The MACD of 2.81 indicates Negative momentum. The RSI at 62.71 is Neutral, neither overbought nor oversold. The STOCH value of 63.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4492.

Genetec Corp. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (57)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
¥5.88B21.91
0.59%10.58%29.96%
77
Outperform
¥5.14B23.88
2.99%14.90%-1.40%
73
Outperform
¥5.33B12.50
3.89%13.66%0.93%
69
Neutral
¥5.40B13.55
1.89%7.19%-2.13%
66
Neutral
¥4.59B211.41
2.52%-0.26%-75.64%
57
Neutral
$899.15M11.56-16.27%2.29%10.33%-39.65%
47
Neutral
¥5.72B
-3.01%95.93%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4492
Genetec Corp.
460.00
-196.20
-29.90%
JP:2321
Softfront Holdings
110.00
30.00
37.50%
JP:3841
Jedat Inc.
1,338.00
-1,165.94
-46.56%
JP:4060
rakumo Inc.
1,014.00
-5.14
-0.50%
JP:4491
Computer Management Co., Ltd.
2,652.00
1,019.39
62.44%
JP:4829
Nihon Enterprise Co., Ltd.
119.00
-12.68
-9.63%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 10, 2025